tiprankstipranks
Wave Life Sciences Pte. Ltd (WVE)
NASDAQ:WVE
US Market
WVE
Wave Life Sciences
RESEARCH TOOLSreports
Want to see WVE full AI Analyst Report?

Wave Life Sciences (WVE) Stock Forecast & Price Target

1,398 Followers
See the Price Targets and Ratings of:

WVE Analyst Ratings

Strong Buy
16Ratings
Strong Buy
16 Buy
0 Hold
0 Sell
Based on 16 analysts giving stock ratings to
Wave
Life Sciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

WVE Stock 12 Month Forecast

Average Price Target

$24.00
▲(220.43% Upside)
Based on 16 Wall Street analysts offering 12 month price targets for Wave Life Sciences in the last 3 months. The average price target is $24.00 with a high forecast of $43.00 and a low forecast of $13.00. The average price target represents a 220.43% change from the last price of $7.49.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","44":"$44","14.75":"$14.75","24.5":"$24.5","34.25":"$34.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$43.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$24.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$13.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,14.75,24.5,34.25,44],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.32,10.064615384615385,12.80923076923077,15.553846153846154,18.298461538461538,21.043076923076924,23.787692307692307,26.53230769230769,29.276923076923076,32.02153846153846,34.76615384615384,37.51076923076923,40.255384615384614,{"y":43,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.32,8.603076923076923,9.886153846153846,11.169230769230769,12.452307692307691,13.735384615384614,15.018461538461539,16.301538461538463,17.584615384615383,18.86769230769231,20.150769230769228,21.433846153846154,22.716923076923077,{"y":24,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.32,7.756923076923077,8.193846153846154,8.63076923076923,9.067692307692308,9.504615384615384,9.941538461538462,10.378461538461538,10.815384615384616,11.252307692307692,11.689230769230768,12.126153846153846,12.563076923076924,{"y":13,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.94,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.25,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.515,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.63,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.62,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.03,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.04,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.41,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.43,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.85,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.83,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.32,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$43.00Average Price Target$24.00Lowest Price Target$13.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on WVE
Benjamin Burnett
Wells Fargo
Wells Fargo
$13→$14
Buy
86.92%
Upside
Assigned
05/20/26
Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (NASDAQ: RLAY) and Wave Life Sciences (NASDAQ: WVE)
H.C. Wainwright Analyst forecast on WVE
Andrew Fein
H.C. Wainwright
H.C. Wainwright
$18→$13
Buy
73.56%
Upside
Reiterated
05/19/26
Wave Life Sciences price target lowered to $13 from $18 at H.C. WainwrightWave Life Sciences price target lowered to $13 from $18 at H.C. Wainwright
Canaccord Genuity Analyst forecast on WVE
Whitney Ijem
Canaccord Genuity
Canaccord Genuity
$43
Buy
474.10%
Upside
Reiterated
05/19/26
Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (NASDAQ: KYMR) and Wave Life Sciences (NASDAQ: WVE)
Truist Financial Analyst forecast on WVE
Danielle Brill
Truist Financial
Truist Financial
―
Buy
―
Reiterated
05/19/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wedbush Analyst forecast on WVE
Yun Zhong
Wedbush
Wedbush
$15
Buy
100.27%
Upside
Reiterated
05/19/26
Wave Life Sciences: Buy Rating Reaffirmed as WVE-006 Data Strengthen Case for Accelerated Pathway; $15 Price Target Maintained
Cantor Fitzgerald Analyst forecast on WVE
Steven Seedhouse
Cantor Fitzgerald
Cantor Fitzgerald
$13
Buy
73.56%
Upside
Reiterated
05/18/26
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (NASDAQ: WVE), Gossamer Bio (NASDAQ: GOSS) and Cullinan Management (NASDAQ: CGEM)
Citi Analyst forecast on WVE
Samantha Semenkow
Citi
Citi
$30→$24
Buy
220.43%
Upside
Assigned
05/01/26
Wave Life Sciences price target lowered to $24 from $30 at CitiWave Life Sciences price target lowered to $24 from $30 at Citi
B. Riley Securities Analyst forecast on WVE
Madison Elsaadi
B. Riley Securities
B. Riley Securities
$37→$31
Buy
313.89%
Upside
Assigned
04/30/26
Analysts' Top Healthcare Picks: Spyre Therapeutics (SYRE), AxoGen (AXGN)
Clear Street Analyst forecast on WVE
William Maughan
Clear Street
Clear Street
$39→$36
Buy
380.64%
Upside
Reiterated
04/28/26
Wave Life Sciences price target lowered to $36 from $39 at Clear StreetWave Life Sciences price target lowered to $36 from $39 at Clear Street
Bank of America Securities Analyst forecast on WVE
Alec Stranahan
Bank of America Securities
Bank of America Securities
$21→$19
Buy
153.67%
Upside
Reiterated
04/28/26
Bank of America Securities Sticks to Their Buy Rating for Wave Life Sciences (WVE)
RBC Capital Analyst forecast on WVE
Luca Issi
RBC Capital
RBC Capital
$15
Buy
100.27%
Upside
Reiterated
04/28/26
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (NASDAQ: WVE), Universal Health (NYSE: UHS) and Pfizer (NYSE: PFE)
Leerink Partners Analyst forecast on WVE
Joseph Schwartz
Leerink Partners
Leerink Partners
$35→$25
Buy
233.78%
Upside
Reiterated
03/26/26
Leerink says Wave Life Sciences selloff 'very overdone' after early obesity dataLeerink says Wave Life Sciences selloff 'very overdone' after early obesity data
JonesTrading Analyst forecast on WVE
Catherine Novack
JonesTrading
JonesTrading
$35
Buy
367.29%
Upside
Reiterated
03/26/26
Wave Life may not be competitive against GLP-1s, says JonesResearchWave Life may not be competitive against GLP-1s, says JonesResearch
Jefferies Analyst forecast on WVE
Roger Song
Jefferies
Jefferies
$28→$18
Buy
140.32%
Upside
Assigned
03/26/26
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (NASDAQ: WVE) and Kodiak Sciences (NASDAQ: KOD)
Mizuho Securities Analyst forecast on WVE
Salim Syed
Mizuho Securities
Mizuho Securities
$22→$27
Buy
260.48%
Upside
Reiterated
03/24/26
Mizuho Securities Reaffirms Their Buy Rating on Wave Life Sciences (WVE)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on WVE
Benjamin Burnett
Wells Fargo
Wells Fargo
$13→$14
Buy
86.92%
Upside
Assigned
05/20/26
Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (NASDAQ: RLAY) and Wave Life Sciences (NASDAQ: WVE)
H.C. Wainwright Analyst forecast on WVE
Andrew Fein
H.C. Wainwright
H.C. Wainwright
$18→$13
Buy
73.56%
Upside
Reiterated
05/19/26
Wave Life Sciences price target lowered to $13 from $18 at H.C. WainwrightWave Life Sciences price target lowered to $13 from $18 at H.C. Wainwright
Canaccord Genuity Analyst forecast on WVE
Whitney Ijem
Canaccord Genuity
Canaccord Genuity
$43
Buy
474.10%
Upside
Reiterated
05/19/26
Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (NASDAQ: KYMR) and Wave Life Sciences (NASDAQ: WVE)
Truist Financial Analyst forecast on WVE
Danielle Brill
Truist Financial
Truist Financial
―
Buy
―
Reiterated
05/19/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wedbush Analyst forecast on WVE
Yun Zhong
Wedbush
Wedbush
$15
Buy
100.27%
Upside
Reiterated
05/19/26
Wave Life Sciences: Buy Rating Reaffirmed as WVE-006 Data Strengthen Case for Accelerated Pathway; $15 Price Target Maintained
Cantor Fitzgerald Analyst forecast on WVE
Steven Seedhouse
Cantor Fitzgerald
Cantor Fitzgerald
$13
Buy
73.56%
Upside
Reiterated
05/18/26
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (NASDAQ: WVE), Gossamer Bio (NASDAQ: GOSS) and Cullinan Management (NASDAQ: CGEM)
Citi Analyst forecast on WVE
Samantha Semenkow
Citi
Citi
$30→$24
Buy
220.43%
Upside
Assigned
05/01/26
Wave Life Sciences price target lowered to $24 from $30 at CitiWave Life Sciences price target lowered to $24 from $30 at Citi
B. Riley Securities Analyst forecast on WVE
Madison Elsaadi
B. Riley Securities
B. Riley Securities
$37→$31
Buy
313.89%
Upside
Assigned
04/30/26
Analysts' Top Healthcare Picks: Spyre Therapeutics (SYRE), AxoGen (AXGN)
Clear Street Analyst forecast on WVE
William Maughan
Clear Street
Clear Street
$39→$36
Buy
380.64%
Upside
Reiterated
04/28/26
Wave Life Sciences price target lowered to $36 from $39 at Clear StreetWave Life Sciences price target lowered to $36 from $39 at Clear Street
Bank of America Securities Analyst forecast on WVE
Alec Stranahan
Bank of America Securities
Bank of America Securities
$21→$19
Buy
153.67%
Upside
Reiterated
04/28/26
Bank of America Securities Sticks to Their Buy Rating for Wave Life Sciences (WVE)
RBC Capital Analyst forecast on WVE
Luca Issi
RBC Capital
RBC Capital
$15
Buy
100.27%
Upside
Reiterated
04/28/26
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (NASDAQ: WVE), Universal Health (NYSE: UHS) and Pfizer (NYSE: PFE)
Leerink Partners Analyst forecast on WVE
Joseph Schwartz
Leerink Partners
Leerink Partners
$35→$25
Buy
233.78%
Upside
Reiterated
03/26/26
Leerink says Wave Life Sciences selloff 'very overdone' after early obesity dataLeerink says Wave Life Sciences selloff 'very overdone' after early obesity data
JonesTrading Analyst forecast on WVE
Catherine Novack
JonesTrading
JonesTrading
$35
Buy
367.29%
Upside
Reiterated
03/26/26
Wave Life may not be competitive against GLP-1s, says JonesResearchWave Life may not be competitive against GLP-1s, says JonesResearch
Jefferies Analyst forecast on WVE
Roger Song
Jefferies
Jefferies
$28→$18
Buy
140.32%
Upside
Assigned
03/26/26
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (NASDAQ: WVE) and Kodiak Sciences (NASDAQ: KOD)
Mizuho Securities Analyst forecast on WVE
Salim Syed
Mizuho Securities
Mizuho Securities
$22→$27
Buy
260.48%
Upside
Reiterated
03/24/26
Mizuho Securities Reaffirms Their Buy Rating on Wave Life Sciences (WVE)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Wave Life Sciences

3 Months
Joseph SchwartzLeerink Partners
Success Rate
10/20 ratings generated profit
50%
Average Return
+14.99%
Copying Joseph Schwartz's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +14.99% per trade.
1 Year
Joseph SchwartzLeerink Partners
Success Rate
14/20 ratings generated profit
70%
Average Return
+23.62%
Copying Joseph Schwartz's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +23.62% per trade.
2 Years
Joseph SchwartzLeerink Partners
Success Rate
10/20 ratings generated profit
50%
Average Return
+15.14%
Copying Joseph Schwartz's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +15.14% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WVE Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
19
24
27
34
32
Buy
12
14
5
3
1
Hold
1
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
32
38
32
37
33
In the current month, WVE has received 33 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. WVE average Analyst price target in the past 3 months is 24.00.
Each month's total comprises the sum of three months' worth of ratings.

WVE Financial Forecast

WVE Earnings Forecast

Next quarter’s earnings estimate for WVE is -$0.30 with a range of -$0.36 to -$0.25. The previous quarter’s EPS was -$0.13. WVE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year WVE has Performed in-line its overall industry.
Next quarter’s earnings estimate for WVE is -$0.30 with a range of -$0.36 to -$0.25. The previous quarter’s EPS was -$0.13. WVE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year WVE has Performed in-line its overall industry.

WVE Sales Forecast

Next quarter’s sales forecast for WVE is $7.65M with a range of $0.00 to $19.00M. The previous quarter’s sales results were $38.25M. WVE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year WVE has Performed in-line its overall industry.
Next quarter’s sales forecast for WVE is $7.65M with a range of $0.00 to $19.00M. The previous quarter’s sales results were $38.25M. WVE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year WVE has Performed in-line its overall industry.

WVE Stock Forecast FAQ

What is WVE’s average 12-month price target, according to analysts?
Based on analyst ratings, Wave Life Sciences Pte. Ltd’s 12-month average price target is 24.00.
    What is WVE’s upside potential, based on the analysts’ average price target?
    Wave Life Sciences Pte. Ltd has 220.43% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is WVE a Buy, Sell or Hold?
          Wave Life Sciences Pte. Ltd has a consensus rating of Strong Buy which is based on 16 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Wave Life Sciences Pte. Ltd’s price target?
            The average price target for Wave Life Sciences Pte. Ltd is 24.00. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $43.00 ,the lowest forecast is $13.00. The average price target represents 220.43% Increase from the current price of $7.49.
              What do analysts say about Wave Life Sciences Pte. Ltd?
              Wave Life Sciences Pte. Ltd’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
                How can I buy shares of WVE?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.